Proactiveinvestors United Kingdom Evgen Pharma https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom Evgen Pharma RSS feed en Wed, 12 Dec 2018 20:35:23 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - Evgen Pharma shares dive as losses widen ]]> https://www.proactiveinvestors.co.uk/companies/news/211061/evgen-pharma-shares-dive-as-losses-widen-211061.html Evgen Pharma PLC (LON:EVG) shares dived on Wednesday after it reported slightly wider first half losses.

The drug development group said its total losses widened to £1.8mln in the six months to the end of September compared to a loss of £1.7mln a year ago. Its net cash outflow fell to £1.5mln from £1.7mln last time, while its cash and short-term investments were flat at £2.2mln.

READ: Evgen Pharma raises £2.3mln to fund its two clinical trials

Evgen said it had not generated any revenue during the period, given it focused on the discovery of new drugs.

"We were delighted with the positive breast cancer interim data showing good tolerability and efficacy in this very difficult to treat patient population and are hopeful that these trends will be maintained in the final analysis,” CEO Stephen Franklin said in a statement.

“With final read-outs of the STEM and SAS clinical trials due in the first and second quarter of 2019 respectively we are excited about the near-term prospects of the company," he added,

Analysts at Northland Capital Partners said news on the STEM trial represented a “key inflection point” for the company.

“Evgen holds a leading position in the therapeutic use of sulforaphane and we expect Evgen to be involved in any future use of sulforaphane in these indications,” they said.

Shares in Evgen were 12% down at 14.75p in early afternoon trade.

]]>
Wed, 12 Dec 2018 13:27:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/211061/evgen-pharma-shares-dive-as-losses-widen-211061.html
<![CDATA[RNS press release - Interim Results ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181212070002_13900092/ Wed, 12 Dec 2018 07:00:02 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181212070002_13900092/ <![CDATA[RNS press release - Nominated Adviser Status ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181210150003_13898040/ Mon, 10 Dec 2018 15:00:03 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181210150003_13898040/ <![CDATA[RNS press release - Poster Presentation of SFX-01 and Trial Update ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181204070006_13889881/ Tue, 04 Dec 2018 07:00:06 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181204070006_13889881/ <![CDATA[RNS press release - Notification of Half Year Results ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181203070008_13888015/ Mon, 03 Dec 2018 07:00:08 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181203070008_13888015/ <![CDATA[RNS press release - Investor Presentation in Manchester ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181119070006_13871054/ Mon, 19 Nov 2018 07:00:06 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181119070006_13871054/ <![CDATA[RNS press release - Directorate Changes ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181108070016_13859323/ Thu, 08 Nov 2018 07:00:16 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181108070016_13859323/ <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181023095754_13838905/ Tue, 23 Oct 2018 09:57:54 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181023095754_13838905/ <![CDATA[RNS press release - Placing ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181018070008_13833114/ Thu, 18 Oct 2018 07:00:08 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20181018070008_13833114/ <![CDATA[RNS press release - Investor Symposium ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180918070004_13793947/ Tue, 18 Sep 2018 07:00:04 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180918070004_13793947/ <![CDATA[RNS press release - Notice of Investor Symposium ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180911070018_13785562/ Tue, 11 Sep 2018 07:00:18 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180911070018_13785562/ <![CDATA[RNS press release - Result of AGM ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180726152250_13733152/ Thu, 26 Jul 2018 15:22:50 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180726152250_13733152/ <![CDATA[RNS press release - AGM Statement ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180726070022_13731777/ Thu, 26 Jul 2018 07:00:22 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180726070022_13731777/ <![CDATA[RNS press release - Final Patient Recruited in STEM Phase IIa Trial ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180725070005_13729973/ Wed, 25 Jul 2018 07:00:05 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180725070005_13729973/ <![CDATA[RNS press release - Grant of share options, issue of equity and TVR ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180710110003_13712146/ Tue, 10 Jul 2018 11:00:03 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180710110003_13712146/ <![CDATA[RNS press release - Posting of Annual Report and AGM Notice ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180621123003_13688939/ Thu, 21 Jun 2018 12:30:03 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180621123003_13688939/ <![CDATA[RNS press release - Full Year Results ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180613070006_13677202/ Wed, 13 Jun 2018 07:00:06 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180613070006_13677202/ <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180611090530_13674198/ Mon, 11 Jun 2018 09:05:30 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180611090530_13674198/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180611090022_13674180/ Mon, 11 Jun 2018 09:00:22 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180611090022_13674180/ <![CDATA[RNS press release - Interim Update on STEM Trial ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180611070003_13673651/ Mon, 11 Jun 2018 07:00:03 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180611070003_13673651/ <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180607164031_13671646/ Thu, 07 Jun 2018 16:40:31 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180607164031_13671646/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180607163514_13671638/ Thu, 07 Jun 2018 16:35:14 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180607163514_13671638/ <![CDATA[RNS press release - Notification of Preliminary Results ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180530070010_13658960/ Wed, 30 May 2018 07:00:10 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180530070010_13658960/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180515110024_13641614/ Tue, 15 May 2018 11:00:24 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180515110024_13641614/ <![CDATA[RNS press release - Upcoming Investor Presentations ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180514070011_13639038/ Mon, 14 May 2018 07:00:11 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180514070011_13639038/ <![CDATA[RNS press release - Grant of further European patent ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180502070013_13626601/ Wed, 02 May 2018 07:00:13 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180502070013_13626601/ <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180426164020_13620662/ Thu, 26 Apr 2018 16:40:20 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180426164020_13620662/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180426163533_13620649/ Thu, 26 Apr 2018 16:35:33 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180426163533_13620649/ <![CDATA[RNS press release - Presentation at World Orphan Drug Congress USA ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180424070002_13615390/ Tue, 24 Apr 2018 07:00:02 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180424070002_13615390/ <![CDATA[RNS press release - Research Collaboration with Imperial College ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180320070003_13572824/ Tue, 20 Mar 2018 07:00:03 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180320070003_13572824/ <![CDATA[RNS press release - Update on Novel Sulforaphane Analogues ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180305070006_13553809/ Mon, 05 Mar 2018 07:00:06 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180305070006_13553809/ <![CDATA[RNS press release - Poster Presentation of SFX-01 Mechanistic Data ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180115070004_13495582/ Mon, 15 Jan 2018 07:00:04 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180115070004_13495582/ <![CDATA[RNS press release - Notification of Major Interest in Shares ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180110163154_13492104/ Wed, 10 Jan 2018 16:31:54 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180110163154_13492104/ <![CDATA[RNS press release - Notification of Major Interest in Shares ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180105094910_13486807/ Fri, 05 Jan 2018 09:49:10 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180105094910_13486807/ <![CDATA[RNS press release - Notification of Major Interest in Shares ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180105094837_13486806/ Fri, 05 Jan 2018 09:48:37 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180105094837_13486806/ <![CDATA[RNS press release - Total Voting Rights ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180102174453_13482928/ Tue, 02 Jan 2018 17:44:53 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20180102174453_13482928/ <![CDATA[RNS press release - Result of General Meeting ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171228114935_13479208/ Thu, 28 Dec 2017 11:49:35 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171228114935_13479208/ <![CDATA[RNS press release - Grant of Options ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171222101019_13475923/ Fri, 22 Dec 2017 10:10:19 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171222101019_13475923/ <![CDATA[RNS press release - Collaboration with King's College London ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171213070003_13463209/ Wed, 13 Dec 2017 07:00:03 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171213070003_13463209/ <![CDATA[RNS press release - Hardman Res.: Funded to the end of Phase II trials ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171211071501_13460343/ Mon, 11 Dec 2017 07:15:01 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171211071501_13460343/ <![CDATA[News - Evgen Pharma raises £2.3mln to fund its two clinical trials ]]> https://www.proactiveinvestors.co.uk/companies/news/188497/evgen-pharma-raises-23mln-to-fund-its-two-clinical-trials-188497.html Evgen Pharma plc (LON:EVG) has applied a meaty discount to its shares in order to get its £2.3mln fundraiser away.

Investors who took part in the placing received new paper at 12p. The stock, which closed at 17p on Thursday after opening at 20.5p, was changing hands for around 27p in October and almost 30p in February.

READ: Evgen Pharma and the power of plants for potential drug breakthrough

The proceeds from the share sale will be used to progress two phase II clinical trials involving patients with subarachnoid haemorrhage (a type of stroke) and metastatic breast cancer.

The company in its half-yearly update said it is making “exciting progress” with the studies and will be reporting data next year.

READ: Evgen Pharma shares jump after positive updates on two Phase II clinical trials for its SFX-01 treatment

“The additional funds will provide valuable working capital as we drive forward our pioneering work in sulforaphane-based therapeutics," said chief executive Steve Franklin.

]]>
Fri, 08 Dec 2017 07:48:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/188497/evgen-pharma-raises-23mln-to-fund-its-two-clinical-trials-188497.html
<![CDATA[RNS press release - Placing and Notice of General Meeting ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171208071501_13458766/ Fri, 08 Dec 2017 07:15:01 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171208071501_13458766/ <![CDATA[RNS press release - Interim Results ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171208070003_13458415/ Fri, 08 Dec 2017 07:00:03 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171208070003_13458415/ <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171123110548_13441984/ Thu, 23 Nov 2017 11:05:48 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171123110548_13441984/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171123110034_13441975/ Thu, 23 Nov 2017 11:00:34 +0000 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171123110034_13441975/ <![CDATA[RNS press release - First European Patent Grant ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171004070005_13385022/ Wed, 04 Oct 2017 07:00:05 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20171004070005_13385022/ <![CDATA[RNS press release - Issue of Equity and Total Voting Rights ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20170831070005_13346513/ Thu, 31 Aug 2017 07:00:05 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20170831070005_13346513/ <![CDATA[RNS press release - SFX-01 data published in Peer Reviewed Journal ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20170802130001_13317017/ Wed, 02 Aug 2017 13:00:01 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20170802130001_13317017/ <![CDATA[RNS press release - AGM Statement ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20170726070003_13307366/ Wed, 26 Jul 2017 07:00:03 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20170726070003_13307366/ <![CDATA[RNS press release - Charity-funded Study of SFX-01 in TNBC ]]> https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20170711123001_13291097/ Tue, 11 Jul 2017 12:30:01 +0100 https://www.proactiveinvestors.co.uk/companies/rns/14248/LSE20170711123001_13291097/